- Home
- PMN vs EDSA Comparison
PMN vs EDSA Comparison
Compare PMN & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- EDSA
- Stock Information
- Founded
- PMN 2004
- EDSA 2015
- Country
- PMN Canada
- EDSA Canada
- Employees
- PMN N/A
- EDSA N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- PMN Health Care
- EDSA Health Care
- Exchange
- PMN Nasdaq
- EDSA Nasdaq
- Market Cap
- PMN 17.0M
- EDSA 13.8M
- IPO Year
- PMN N/A
- EDSA N/A
- Fundamental
- Price
- PMN $0.49
- EDSA $2.05
- Analyst Decision
- PMN Strong Buy
- EDSA Strong Buy
- Analyst Count
- PMN 2
- EDSA 2
- Target Price
- PMN $4.50
- EDSA $13.00
- AVG Volume (30 Days)
- PMN 42.3K
- EDSA 33.4K
- Earning Date
- PMN 08-07-2025
- EDSA 08-08-2025
- Dividend Yield
- PMN N/A
- EDSA N/A
- EPS Growth
- PMN N/A
- EDSA N/A
- EPS
- PMN N/A
- EDSA N/A
- Revenue
- PMN N/A
- EDSA N/A
- Revenue This Year
- PMN N/A
- EDSA N/A
- Revenue Next Year
- PMN N/A
- EDSA N/A
- P/E Ratio
- PMN N/A
- EDSA N/A
- Revenue Growth
- PMN N/A
- EDSA N/A
- 52 Week Low
- PMN $0.47
- EDSA $1.55
- 52 Week High
- PMN $2.37
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- PMN 43.83
- EDSA 52.89
- Support Level
- PMN $0.48
- EDSA $1.91
- Resistance Level
- PMN $0.53
- EDSA $2.14
- Average True Range (ATR)
- PMN 0.03
- EDSA 0.12
- MACD
- PMN 0.00
- EDSA 0.02
- Stochastic Oscillator
- PMN 21.29
- EDSA 64.52
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.